HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nafarelin in the treatment of pelvic pain caused by endometriosis.

Abstract
As part of a large, multicenter trial, 82 patients with endometriosis were randomized to 6 months of treatment with either nafarelin or danazol. Among 73 patients who had subjective symptoms (dysmenorrhea, dyspareunia, or pelvic pain) at baseline, 94% of patients treated with nafarelin and 91% of those treated with danazol had improvement. Resolution of physical findings also was observed in similar percentages of patients in each treatment group. Long-term studies are needed to determine whether these two agents are associated with different cure rates or times to recurrence of disease.
AuthorsR W Shaw
JournalAmerican journal of obstetrics and gynecology (Am J Obstet Gynecol) Vol. 162 Issue 2 Pg. 574-6 (Feb 1990) ISSN: 0002-9378 [Print] United States
PMID2137972 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Nafarelin
  • Gonadotropin-Releasing Hormone
  • Danazol
Topics
  • Amenorrhea (chemically induced)
  • Clinical Trials as Topic
  • Danazol (therapeutic use)
  • Endometriosis (drug therapy)
  • Female
  • Gonadotropin-Releasing Hormone (analogs & derivatives, therapeutic use)
  • Humans
  • Nafarelin
  • Pain (drug therapy, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: